Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation

NCT06026371 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

138

Enrollment

OTHER

Sponsor class

Conditions

Acute Graft Versus Host Disease
Hematopoietic and Lymphatic System Neoplasm

Interventions

DRUG: Fecal Microbiota Transplantation Capsule
DRUG: Placebo

Sponsor

Fred Hutchinson Cancer Center